Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07658937 · ClinicalTrials.gov registry record · NA
Improving Sexual and Reproductive Health Communication for Adolescent and Young Adult Oncology Patients
A NA study, sponsored by Connecticut Children's Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT07658937 is a NA study that has not yet begun recruiting, run by Connecticut Children's Medical Center. The registered enrollment target is 30 participants.
The verdict
NCT07658937, a NA study, has not yet begun recruiting, sponsored by Connecticut Children's Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if ReSPECT, which includes a pre-visit checklist for patients to complete and an informational website, can work well in practice to help adolescent and young adult oncology patients communicate with their clinicians about sexual and reproductive health (SRH). SRH includes topics such as how cancer may impact puberty and development, best methods for contraception during cancer treatment, fertility risk and fertility preservation strategies, and dating/relationships during and after cancer. The study will also help researchers better understand how to best measure the impact of ReSPECT on improving SRH communication for future testing of ReSPECT. The main questions the study aims to answer are: How well does ReSPECT work in practice? Do patients and clinicians like ReSPECT, and do they find it helpful? What are the best ways to test ReSPECT and measure whether it works? Participants will: Use ReSPECT to support a conversation about SRH during an outpatient oncology clinic appointment Complete surveys before and after using ReSPECT Provide feedback on their experience using ReSPECT in a short interview
Interventions
- BEHAVIORAL ReSPECT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-11-15 |
| Est. Completion | 2029-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07658937
The ClinicalTrials.gov registry entry for NCT07658937 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Connecticut Children's Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ReSPECT is the first listed.
NCT07658937 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07658937 about?
NCT07658937 is a clinical study titled "Improving Sexual and Reproductive Health Communication for Adolescent and Young Adult Oncology Patients". The goal of this clinical trial is to learn if ReSPECT, which includes a pre-visit checklist for patients to complete and an informational website, can work well in practice to help adolescent and young adult oncology patients communicate with their clinicians about sexual and reproductive health (S...
What is the current status of trial NCT07658937?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-11-15. Estimated completion is 2029-06-30.
What interventions are being tested in trial NCT07658937?
The interventions under investigation include: ReSPECT (BEHAVIORAL).
Who is sponsoring clinical trial NCT07658937?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.